Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations. [electronic resource]
- The Korean journal of internal medicine Nov 2016
- 1140-1149 p. digital
Publication Type: Journal Article
2005-6648
10.3904/kjim.2015.062 doi
Adult Aged Aged, 80 and over Anemia--blood Antineoplastic Agents--therapeutic use Body Mass Index Carcinoma, Non-Small-Cell Lung--drug therapy Disease-Free Survival ErbB Receptors--antagonists & inhibitors Erlotinib Hydrochloride--therapeutic use Female Gefitinib Genetic Predisposition to Disease Humans Kaplan-Meier Estimate Lung Neoplasms--drug therapy Male Middle Aged Molecular Targeted Therapy Multivariate Analysis Mutation Nutrition Assessment Nutritional Status Phenotype Proportional Hazards Models Protein Kinase Inhibitors--therapeutic use Quinazolines--therapeutic use Retrospective Studies Risk Factors Time Factors Treatment Outcome